Brief: Biontech Closes Acquisition Of CureVac
18/12/2025 09:45
Dec 18 (Reuters) - BIONTECH 22UAy.DE: CLOSES ACQUISITION OF CUREVAC ABOUT 86.75% OF CUREVAC SHARES WERE TENDERED CUREVAC WILL CONTINUE OPERATIONS IN ACCORDANCE WITH EXISTING BUSINESS PROCESSES WILL COMPLETE ANALYSES NECESSARY TO DETERMINE FUTURE ORGANIZATIONAL AND PORTFOLIO STRUCTURE EXPECTS MANDATORY ACQUISITION OF REMAINING SHARES TO BE CARRIED OUT IN JAN 2026 Further company coverage: 22UAy.DE (Gdansk Newsroom) ((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on CureVac NV
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: Biontech Closes Acquisition Of CureVac
Brief: BioNTech Says CureVac Shareholders Are Advised To Tender Their Shares By 6:00 P.M. Eastern Time On Tuesday, December 2, 2025
Brief: Curevac Reaffirms Its Expected Cash Runway Into 2028